AUB
VKTX icon

Atlantic Union Bankshares’s Viking Therapeutics VKTX Stock Holding History

Atlantic Union Bankshares’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-100
Closed -$3.25K – 1855
2026
Q1 		$3.25K Hold
100
– – ﹤0.01% 1492
2025
Q4 		$3.52K Sell
100
-35
-26% -$1.24K ﹤0.01% 1438
2025
Q3 		$3.55K Hold
135
– – ﹤0.01% 1419
2025
Q2 		$3.58K Buy
+135
New +$3.55K ﹤0.01% 1027

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Atlantic Union Bankshares's VKTX Position: Q2 2026 in Review

Atlantic Union Bankshares sold out of Viking Therapeutics (VKTX) in Q2 2026, closing a stake of 100 shares — an estimated $3.25K sold.

Atlantic Union Bankshares first reported a position in VKTX in Q2 2025 and held it in 4 quarters. The position peaked at $3.58K in Q2 2025. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Atlantic Union Bankshares reported no remaining Viking Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Atlantic Union Bankshares sold 100 Viking Therapeutics shares in Q2 2026, an estimated $3.25K.
  • Atlantic Union Bankshares first reported a position in Viking Therapeutics in Q2 2025 and held it in 4 quarters.
  • Atlantic Union Bankshares's Viking Therapeutics position peaked at $3.58K in Q2 2025.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Atlantic Union Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.